148 related articles for article (PubMed ID: 24483347)
1. Response evaluation and monitoring of multiple myeloma.
Fernández de Larrea C; Delforge M; Davies F; Bladé J
Expert Rev Hematol; 2014 Feb; 7(1):33-42. PubMed ID: 24483347
[TBL] [Abstract][Full Text] [Related]
2. Role of serum free light chain assay in the detection of early relapse and prediction of prognosis after relapse in multiple myeloma patients treated upfront with novel agents.
Tacchetti P; Pezzi A; Zamagni E; Pantani L; Rocchi S; Zannetti BA; Mancuso K; Rizzello I; Cavo M
Haematologica; 2017 Mar; 102(3):e104-e107. PubMed ID: 27909220
[No Abstract] [Full Text] [Related]
3. Molecular monitoring of minimal residual disease in the peripheral blood of patients with multiple myeloma.
Korthals M; Sehnke N; Kronenwett R; Schroeder T; Strapatsas T; Kobbe G; Haas R; Fenk R
Biol Blood Marrow Transplant; 2013 Jul; 19(7):1109-15. PubMed ID: 23644045
[TBL] [Abstract][Full Text] [Related]
4. What is the significance of molecular remission in multiple myeloma?
Tricot GJ
Clin Adv Hematol Oncol; 2007 Feb; 5(2):91-5. PubMed ID: 17344796
[TBL] [Abstract][Full Text] [Related]
5. Role of new treatment approaches in defining treatment goals in multiple myeloma--the ultimate goal is extended survival.
Durie BG
Cancer Treat Rev; 2010 May; 36 Suppl 2():S18-23. PubMed ID: 20472184
[TBL] [Abstract][Full Text] [Related]
6. Minimal residual disease in myeloma: are we there yet?
Hart AJ; Jagasia MH; Kim AS; Mosse CA; Savani BN; Kassim A
Biol Blood Marrow Transplant; 2012 Dec; 18(12):1790-9. PubMed ID: 22626785
[TBL] [Abstract][Full Text] [Related]
7. Second autologous stem cell transplantation as salvage therapy for multiple myeloma: impact on progression-free and overall survival.
Jimenez-Zepeda VH; Mikhael J; Winter A; Franke N; Masih-Khan E; Trudel S; Chen C; Kukreti V; Reece DE
Biol Blood Marrow Transplant; 2012 May; 18(5):773-9. PubMed ID: 22062804
[TBL] [Abstract][Full Text] [Related]
8. Polymerase chain reaction-based detection of minimal residual disease in multiple myeloma patients receiving allogeneic stem cell transplantation.
Martinelli G; Terragna C; Zamagni E; Ronconi S; Tosi P; Lemoli R; Bandini G; Testoni N; Amabile M; Ottaviani E; Buonamici S; Soverini S; Montefusco V; de Vivo A; Bonifazi F; Tura S; Cavo M
Haematologica; 2000 Sep; 85(9):930-4. PubMed ID: 10980631
[TBL] [Abstract][Full Text] [Related]
9. Smoldering multiple myeloma: when to observe and when to treat?
Mateos MV; San Miguel JF
Am Soc Clin Oncol Educ Book; 2015; ():e484-92. PubMed ID: 25993213
[TBL] [Abstract][Full Text] [Related]
10. Multiple myeloma in serologic complete remission after autologous stem cell transplantation: impact of bone marrow plasma cell assessment by conventional morphology on disease progression.
Fernández de Larrea C; Tovar N; Rozman M; Rosiñol L; Aróstegui JI; Cibeira MT; Rovira M; Yagüe J; Bladé J
Biol Blood Marrow Transplant; 2011 Jul; 17(7):1084-7. PubMed ID: 21215814
[TBL] [Abstract][Full Text] [Related]
11. Different patterns of relapse after autologous peripheral blood stem cell transplantation in multiple myeloma: clinical results of 280 cases from the Spanish Registry.
Alegre A; Granda A; Martínez-Chamorro C; Díaz-Mediavilla J; Martínez R; García-Laraña J; Lahuerta JJ; Sureda A; Bladé J; de la Rubia J; Fernández-Rañada JM; San Miguel J; ; ;
Haematologica; 2002 Jun; 87(6):609-14. PubMed ID: 12031917
[TBL] [Abstract][Full Text] [Related]
12. Post-transplant immunotherapy with donor-lymphocyte infusion and novel agents to upgrade partial into complete and molecular remission in allografted patients with multiple myeloma.
Kröger N; Badbaran A; Lioznov M; Schwarz S; Zeschke S; Hildebrand Y; Ayuk F; Atanackovic D; Schilling G; Zabelina T; Bacher U; Klyuchnikov E; Shimoni A; Nagler A; Corradini P; Fehse B; Zander A
Exp Hematol; 2009 Jul; 37(7):791-8. PubMed ID: 19487069
[TBL] [Abstract][Full Text] [Related]
13. Multiple myeloma.
Kyle RA; Rajkumar SV
N Engl J Med; 2004 Oct; 351(18):1860-73. PubMed ID: 15509819
[No Abstract] [Full Text] [Related]
14. Initial treatment of transplant-eligible patients in multiple myeloma.
Rosiñol L; Kumar S; Moreau P; Cavo M
Expert Rev Hematol; 2014 Feb; 7(1):43-53. PubMed ID: 24392968
[TBL] [Abstract][Full Text] [Related]
15. Molecular monitoring of the tumor load predicts progressive disease in patients with multiple myeloma after high-dose therapy with autologous peripheral blood stem cell transplantation.
Lipinski E; Cremer FW; Ho AD; Goldschmidt H; Moos M
Bone Marrow Transplant; 2001 Nov; 28(10):957-62. PubMed ID: 11753551
[TBL] [Abstract][Full Text] [Related]
16. Autologous stem cell transplantation after first remission induction treatment in multiple myeloma. A report of the French Registry on Autologous Transplantation in Multiple Myeloma.
Harousseau JL; Attal M; Divine M; Marit G; Leblond V; Stoppa AM; Bourhis JH; Caillot D; Boasson M; Abgrall JF
Stem Cells; 1995 Aug; 13 Suppl 2():132-9. PubMed ID: 8520502
[TBL] [Abstract][Full Text] [Related]
17. Bortezomib plus dexamethasone followed by escalating donor lymphocyte infusions for patients with multiple myeloma relapsing or progressing after allogeneic stem cell transplantation.
Montefusco V; Spina F; Patriarca F; Offidani M; Bruno B; Montanari M; Mussetti A; Sperotto A; Scortechini I; Dodero A; Fanin R; Valagussa P; Corradini P
Biol Blood Marrow Transplant; 2013 Mar; 19(3):424-8. PubMed ID: 23142330
[TBL] [Abstract][Full Text] [Related]
18. Double high-dose chemoradiotherapy with autologous stem cell transplantation can induce molecular remissions in multiple myeloma.
Björkstrand B; Ljungman P; Bird JM; Samson D; Gahrton G
Bone Marrow Transplant; 1995 Mar; 15(3):367-71. PubMed ID: 7599560
[TBL] [Abstract][Full Text] [Related]
19. State of the art therapy in multiple myeloma and future perspectives.
Denz U; Haas PS; Wäsch R; Einsele H; Engelhardt M
Eur J Cancer; 2006 Jul; 42(11):1591-600. PubMed ID: 16815703
[TBL] [Abstract][Full Text] [Related]
20. Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation.
Kim JS; Kim K; Cheong JW; Min YH; Suh C; Kim H; Jo DY; Ryoo HM; Yoon SS; Lee JH;
Biol Blood Marrow Transplant; 2009 Apr; 15(4):463-70. PubMed ID: 19285634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
